epirubicin has been researched along with Endocrine Gland Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajetta, E; Buzzoni, R; Castellani, R; Celio, L; de Braud, F; Di Bartolomeo, M; Lorusso, V; Maffioli, L; Villa, E; Zilembo, N | 1 |
1 trial(s) available for epirubicin and Endocrine Gland Neoplasms
| Article | Year |
|---|---|
Salvage treatment after r-interferon alpha-2a in advanced neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adenoma, Islet Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma, Merkel Cell; Drug Administration Schedule; Endocrine Gland Neoplasms; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neurosecretory Systems; Pancreatic Neoplasms; Recombinant Proteins; Salvage Therapy; Streptozocin; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 1993 |